drugset / Trial / NCT01079767
Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
RATIONALE: Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well temsirolimus works in treating patients with advanced liver cancer and cirrhosis.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temsirolimus | Small molecule | — | Intravenous |